生物等效性研究中的分析技术简评

Slesha Kumar Kosuru, Tadi Suvarna Kosuru, Gunapati Jyothi, Kandregula Sai Siva Saran, Polinati Syam Sundhar
{"title":"生物等效性研究中的分析技术简评","authors":"Slesha Kumar Kosuru, Tadi Suvarna Kosuru, Gunapati Jyothi, Kandregula Sai Siva Saran, Polinati Syam Sundhar","doi":"10.61427/jcpr.v4.i1.2024.117","DOIUrl":null,"url":null,"abstract":"In the pharmaceutical research and development, bioequivalence studies hold a critical position, serving as a vital component in evaluating the equivalence of generic drugs with their reference counterparts. These studies, which examine the interchangeability between generic and brand-name medications, depend heavily on a range of analytical techniques to measure the presence and concentration of a drug's active pharmaceutical ingredient (API) within the human body. The comprehensive use of these analytical methods ensures the confidence of healthcare providers and regulatory bodies in the effectiveness, quality and safety of generic medications. The field of pharmaceutical analysis is dynamic and forward-looking, with analysts, researchers and scientists energetically engaged in forging a future characterized by ground breaking discoveries and refined pharmaceutical solutions. This is a realm where scientific excellence and innovation harmonize, ultimately benefiting the health and welfare of individuals and societies across the globe. The key takeaways underscore the field's resilience and its unwavering commitment to upholding the highest standards in drug development and quality control while pioneering cutting-edge technologies with the promise of safer, more effective pharmaceuticals for all.","PeriodicalId":513179,"journal":{"name":"Journal of Clinical and Pharmaceutical Research","volume":"15 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Brief Review on Analytical Techniques in Bioequivalence Studies\",\"authors\":\"Slesha Kumar Kosuru, Tadi Suvarna Kosuru, Gunapati Jyothi, Kandregula Sai Siva Saran, Polinati Syam Sundhar\",\"doi\":\"10.61427/jcpr.v4.i1.2024.117\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In the pharmaceutical research and development, bioequivalence studies hold a critical position, serving as a vital component in evaluating the equivalence of generic drugs with their reference counterparts. These studies, which examine the interchangeability between generic and brand-name medications, depend heavily on a range of analytical techniques to measure the presence and concentration of a drug's active pharmaceutical ingredient (API) within the human body. The comprehensive use of these analytical methods ensures the confidence of healthcare providers and regulatory bodies in the effectiveness, quality and safety of generic medications. The field of pharmaceutical analysis is dynamic and forward-looking, with analysts, researchers and scientists energetically engaged in forging a future characterized by ground breaking discoveries and refined pharmaceutical solutions. This is a realm where scientific excellence and innovation harmonize, ultimately benefiting the health and welfare of individuals and societies across the globe. The key takeaways underscore the field's resilience and its unwavering commitment to upholding the highest standards in drug development and quality control while pioneering cutting-edge technologies with the promise of safer, more effective pharmaceuticals for all.\",\"PeriodicalId\":513179,\"journal\":{\"name\":\"Journal of Clinical and Pharmaceutical Research\",\"volume\":\"15 3\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Clinical and Pharmaceutical Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.61427/jcpr.v4.i1.2024.117\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical and Pharmaceutical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.61427/jcpr.v4.i1.2024.117","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

在医药研发领域,生物等效性研究占据着重要地位,是评估仿制药与其参照药等效性的重要组成部分。这些研究主要考察仿制药和品牌药之间的互换性,主要依靠一系列分析技术来测量药物活性药物成分 (API) 在人体内的存在和浓度。这些分析方法的全面使用确保了医疗服务提供者和监管机构对仿制药有效性、质量和安全性的信心。药物分析领域是一个充满活力和前瞻性的领域,分析师、研究人员和科学家们都在以突破性的发现和完善的药物解决方案为特点,积极地参与到未来的建设中。这是一个科学卓越与创新和谐共存的领域,最终将惠及全球个人和社会的健康与福祉。会议的主要收获强调了这一领域的韧性和坚定不移的承诺,即坚持药物开发和质量控制的最高标准,同时开拓前沿技术,为所有人提供更安全、更有效的药物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
A Brief Review on Analytical Techniques in Bioequivalence Studies
In the pharmaceutical research and development, bioequivalence studies hold a critical position, serving as a vital component in evaluating the equivalence of generic drugs with their reference counterparts. These studies, which examine the interchangeability between generic and brand-name medications, depend heavily on a range of analytical techniques to measure the presence and concentration of a drug's active pharmaceutical ingredient (API) within the human body. The comprehensive use of these analytical methods ensures the confidence of healthcare providers and regulatory bodies in the effectiveness, quality and safety of generic medications. The field of pharmaceutical analysis is dynamic and forward-looking, with analysts, researchers and scientists energetically engaged in forging a future characterized by ground breaking discoveries and refined pharmaceutical solutions. This is a realm where scientific excellence and innovation harmonize, ultimately benefiting the health and welfare of individuals and societies across the globe. The key takeaways underscore the field's resilience and its unwavering commitment to upholding the highest standards in drug development and quality control while pioneering cutting-edge technologies with the promise of safer, more effective pharmaceuticals for all.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Plummer-Vinson Syndrome: A Rare Case Report Impact of Gene Therapy and Genetic Mutations in Rare Diseases A Review on Innovative Drug Delivery Platforms Precision Pharmacogenomics: A Review Integrating Immunotherapy and Nanotechnology in Advanced Drug Delivery Systems for Precision Cancer Therapy
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1